23andMe (ME) News Today $2.42 -0.32 (-11.68%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.52 +0.10 (+4.13%) As of 02/21/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period 23andMe CEO Wojcicki, New Mountain offer to purchase genetic testing companyFebruary 21 at 8:41 PM | msn.comAnne Wojcicki has a new offer to take 23andMe private, this time for $74.7 millionFebruary 21 at 5:30 PM | cnbc.com23andMe's (ME) "Sell (E+)" Rating Reiterated at Weiss RatingsFebruary 20 at 3:11 AM | americanbankingnews.com23andMe (NASDAQ:ME) Given Sell (E+) Rating at Weiss RatingsWeiss Ratings reiterated a "sell (e+)" rating on shares of 23andMe in a research note on Wednesday.February 20 at 2:36 AM | marketbeat.comRory Feek's Daughter Hopie Reveals What She Has 'in Common' with Biological Dad After 23andMe Discovery (Exclusive)February 16, 2025 | msn.comCountry music singer learns his ‘daughter’ is not related to him, though he still loves herFebruary 13, 2025 | nj.comRory Feek's Daughter Says She Learned From a DNA Test That He's Not Her Biological FatherFebruary 13, 2025 | msn.comRory Feek's Daughter Hopie Reveals He Is Not Her Biological Dad, Slams Country Singer for Shaming Mom: 'Disappointing'February 12, 2025 | msn.com23andMe DNA kit leads to shocking diagnosis for Ky. womanFebruary 7, 2025 | msn.comWeiss Ratings Reiterates "Sell (E+)" Rating for 23andMe (NASDAQ:ME)Weiss Ratings reiterated a "sell (e+)" rating on shares of 23andMe in a research note on Saturday.February 4, 2025 | marketbeat.com23andMe Launches New Genetic Report on OsteoporosisJanuary 31, 2025 | globenewswire.com23andMe weighing up sale of the company as cash runs dryJanuary 30, 2025 | msn.com23andMe announces exploration of strategic alternativesJanuary 29, 2025 | markets.businessinsider.com23andMe Board Explores Strategic Alternatives Amid RestructuringJanuary 29, 2025 | finance.yahoo.com23andMe announces continued concerns regarding liquidityJanuary 29, 2025 | markets.businessinsider.comStocks to Watch: 23andMe, Manhattan Associates, NextrackerJanuary 28, 2025 | marketwatch.com23andMe says it's exploring alternatives, including a saleJanuary 28, 2025 | msn.com23andMe Considers Sale as Cash Runs LowJanuary 28, 2025 | wsj.com23andMe is exploring strategic alternatives, looking to raise capitalJanuary 28, 2025 | cnbc.com23andMe (NASDAQ:ME) Releases Quarterly Earnings Results23andMe (NASDAQ:ME - Get Free Report) released its earnings results on Tuesday. The company reported ($1.02) earnings per share for the quarter. 23andMe had a negative net margin of 318.39% and a negative return on equity of 129.98%.January 28, 2025 | marketbeat.com23andMe Special Committee Announces Exploration of Strategic AlternativesJanuary 28, 2025 | globenewswire.com23andMe Reports Third Quarter Fiscal Year 2025 Financial ResultsJanuary 28, 2025 | globenewswire.com23andMe's (ME) Sell (E+) Rating Reiterated at Weiss RatingsWeiss Ratings reiterated a "sell (e+)" rating on shares of 23andMe in a research note on Saturday.January 19, 2025 | marketbeat.com23andMe exploring possible sale of telehealth business, BI reportsJanuary 18, 2025 | markets.businessinsider.com23andMe considers selling its telehealth unit LemonaidJanuary 17, 2025 | msn.com23andMe has been quietly exploring a possible sale of its telehealth business, LemonaidJanuary 17, 2025 | businessinsider.com23andMe Holding Co. (NASDAQ:ME) Shares Sold by NewView Capital Partners I LLCNewView Capital Partners I LLC trimmed its position in shares of 23andMe Holding Co. (NASDAQ:ME - Free Report) by 95.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 972,785 shares of the company's stock aJanuary 16, 2025 | marketbeat.comJane Street Group LLC Lowers Position in 23andMe Holding Co. (NASDAQ:ME)Jane Street Group LLC decreased its position in shares of 23andMe Holding Co. (NASDAQ:ME - Free Report) by 68.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 726,017 shares of the company's stock aJanuary 12, 2025 | marketbeat.comWhat went wrong for 23andMeJanuary 11, 2025 | finance.yahoo.com23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted TechnologyJanuary 9, 2025 | markets.businessinsider.com23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit's Trusted TechnologyJanuary 8, 2025 | globenewswire.comWhat Is Your Horror Story From DNA Tests Like 23andMe?January 8, 2025 | msn.com23andMe (NASDAQ:ME) Stock Price Down 0.3% - Should You Sell?23andMe (NASDAQ:ME) Shares Down 0.3% - Here's What HappenedJanuary 7, 2025 | marketbeat.com3 Promising US Penny Stocks With Over $9M Market CapJanuary 4, 2025 | finance.yahoo.comDeleting Your 23andMe Genetic Data? There's a Way, But Also a CatchDecember 30, 2024 | msn.comDiscover your genetic blueprint with 23andMe — now 57% off on AmazonDecember 26, 2024 | msn.comThese were the badly handled data breaches of 2024December 26, 2024 | msn.comHow safe is my information with DNA ancestry tests?December 20, 2024 | msn.comThis Christmas, ask for genetic testing. It could save your life.December 18, 2024 | msn.comOpinion: 23andMe must secure its DNA databases immediatelyDecember 14, 2024 | msn.com23andMe Holding Co. (NASDAQ:ME) Short Interest Update23andMe Holding Co. (NASDAQ:ME - Get Free Report) was the recipient of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 950,200 shares, a drop of 16.6% from the November 15th total of 1,140,000 shares. Based on an average daily volume of 325,600 shares, the days-to-cover ratio is presently 2.9 days. Currently, 5.9% of the shares of the company are short sold.December 14, 2024 | marketbeat.com23andMe's struggles are a sign that direct-to-consumer DNA testing needs stronger oversightDecember 12, 2024 | msn.com23andMe’s struggles are a sign that direct-to-consumer DNA testing needs stronger oversightDecember 12, 2024 | msn.comWhat’s next for 23andMe?December 10, 2024 | finance.yahoo.comAmid 23andMe's Turbulence, Can You Delete Your Genetic Data? What We KnowDecember 8, 2024 | msn.comThe Kardashians love this 'biological age test' so I tried it. Here's what I learned.December 4, 2024 | msn.com'I share DNA with King Richard III': 23andMe is 65% off — save $150December 4, 2024 | yahoo.com23andMe (NASDAQ:ME) Trading 13.1% Higher - Should You Buy?23andMe (NASDAQ:ME) Shares Up 13.1% - What's Next?November 30, 2024 | marketbeat.comDyslexia And Sense Of Rhythm Are Genetically LinkedNovember 29, 2024 | forbes.comRhode Island native, more than a dozen surprise siblings connect through 23andMeNovember 29, 2024 | msn.com Get 23andMe News Delivered to You Automatically Sign up to receive the latest news and ratings for ME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Videos ME Media Mentions By Week ME Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ME News Sentiment▼-0.240.60▲Average Medical News Sentiment ME News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ME Articles This Week▼66▲ME Articles Average Week Get 23andMe News Delivered to You Automatically Sign up to receive the latest news and ratings for ME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVIR News Today TNGX News Today MNPR News Today SOPH News Today BNTC News Today ENGN News Today AMLX News Today URGN News Today AMRN News Today BTMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ME) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 23andMe Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share 23andMe With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
